TAPAZOLE (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the TAPAZOLE drug offered from Pfizer Laboratories Div Pfizer Inc. This Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
NON-PROPRIETARY NAME: | methimazole |
SUBSTANCE NAME: | METHIMAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-03-31 |
END MARKETING DATE: | 0000-00-00 |
TAPAZOLE HUMAN PRESCRIPTION DRUG Details:
Item Description | TAPAZOLE from Pfizer Laboratories Div Pfizer Inc |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2000-03-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60793-104_acfeef88-87bf-4408-9b40-c1fc5b757418 |
PRODUCT NDC: | 60793-104 |
APPLICATION NUMBER: | ANDA040320 |
Other METHIMAZOLE Pharmaceutical Manufacturers / Labelers: